ResMed Inc.
RMD
Rang in Aktien
#709
ResMed Inc. is a leading global medical technology enterprise engaged in the... ResMed Inc. is a leading global medical technology enterprise engaged in the creation, production, distribution, and marketing of healthcare devices and connected digital solutions. The company operates through two primary segments: Sleep and Respiratory Care, and Software as a Service. Its extensive product range addresses a variety of respiratory disorders, encompassing advanced medical and consumer technologies, ventilation devices, diagnostic equipment, mask systems for both clinical and personal use, headgear, and related accessories, alongside dental devices. ResMed also provides sophisticated cloud-based informatics to enhance patient management and operational efficiency. Notable software offerings in its respiratory portfolio include AirView, for remote device monitoring and setting adjustments; myAir, a personalized application designed to support sleep apnea patients with education and troubleshooting for better engagement and adherence; and U-Sleep, a compliance tracking platform for home medical equipment providers. Complementing these are connectivity modules and Propeller solutions. Furthermore, ResMed offers a robust suite of out-of-hospital software. This includes Brightree, a business management platform for various home care service providers (e.g., HME, pharmacy, infusion, orthotics, prosthetics); MatrixCare, providing care management for senior living, skilled nursing, and hospice organizations; and HEALTHCAREfirst, which supplies electronic health records, billing, coding services, and analytics for home health and hospice agencies. ResMed distributes its offerings primarily to sleep clinics, home healthcare dealers, and hospitals via a global network of distributors and a direct sales force, serving approximately 140 countries. Founded in 1989, the company's headquarters are located in San Diego, California.
Aktienkurs
$245.56
Zuletzt synchronisiert: 2026-10-20
Marktkapitalisierung
$34.54B
Veränderung (1 Tag)
2.47%
Veränderung (1 Jahr)
-8.45%
Land
US
Handel ResMed Inc. (RMD)
Kategorie
Healthcare
Umsatz von ResMed Inc. (RMD)
Umsatz im Jun 2026 TTM: $5.65B
Laut den aktuellen Finanzberichten von ResMed Inc. beträgt der derzeitige Umsatz des Unternehmens (TTM) $5.65B. Im Jahr 2024 erzielte das Unternehmen einen Umsatz von $4.69B eine Steigerung gegenüber dem Umsatz im Jahr 2023, der $4.22B betrug. Der Umsatz ist der Gesamtbetrag, den ein Unternehmen durch den Verkauf von Waren oder Dienstleistungen erzielt. Im Gegensatz zum Gewinn werden keine Ausgaben abgezogen.
Umsatzverlauf für ResMed Inc. von 2000 bis 2026
Umsatz am Ende jedes Jahres
| Jahr | Umsatz | ändert |
|---|---|---|
| 2026 (TTM) | $5.65B | 9.85% |
| 2025 | $5.15B | 9.84% |
| 2024 | $4.69B | 10.95% |
| 2023 | $4.22B | 18.02% |
| 2022 | $3.58B | 11.93% |
| 2021 | $3.20B | 8.11% |
| 2020 | $2.96B | 13.44% |
| 2019 | $2.61B | 11.38% |
| 2018 | $2.34B | 13.23% |
| 2017 | $2.07B | 12.40% |
| 2016 | $1.84B | 9.52% |
| 2015 | $1.68B | 7.97% |
| 2014 | $1.55B | 2.68% |
| 2013 | $1.51B | 10.66% |
| 2012 | $1.37B | 10.08% |
| 2011 | $1.24B | 13.80% |
| 2010 | $1.09B | 18.64% |
| 2009 | $920.74M | 10.22% |
| 2008 | $835.40M | 16.62% |
| 2007 | $716.33M | 18.01% |
| 2006 | $607.00M | 42.65% |
| 2005 | $425.51M | 25.39% |
| 2004 | $339.34M | 24.04% |
| 2003 | $273.57M | 34.05% |
| 2002 | $204.08M | 31.53% |
| 2001 | $155.16M | 34.20% |
| 2000 | $115.62M | 0.00% |
Umsatz vergleichbarer Unternehmen oder Wettbewerber
| Unternehmen | Umsatz | Umsatzunterschied | Land |
|---|---|---|---|
| $46.59B | 724.01% |
US
|
|
| $35.48B | 527.65% |
IE
|
|
| $25.84B | 357.01% |
US
|
|
| $21.00B | 271.38% |
US
|
|
| - | - |
DE
|
